Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Drugs Based on Gene Therapy industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
bluebird bio
Gilead Sciences
Alnylam Pharmaceuticals
Orchard Therapeutics
Sunway Biotech
AnGes
Biogen
Sarepta Therapeutics
Human Stem Cells Institute
Amgen
Spark Therapeutics
Novartis
By Type:
Defitelio
Onpattro
Glybera
Rexin-G
Neovasculgen
Eteplirsen
Others
Spinraza
By Application:
Other
Cancer
Neurological Diseases
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Drugs Based on Gene Therapy Market Overview 2018-2029
-
1.1 China Drugs Based on Gene Therapy Industry Development Overview
-
1.2 China Drugs Based on Gene Therapy Industry Development History
-
1.3 China Drugs Based on Gene Therapy Industry Market Size (2018-2029)
-
1.4 China Drugs Based on Gene Therapy Market Analysis by Type from Production Side
-
1.4.1 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Defitelio (2018-2029)
-
1.4.2 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Onpattro (2018-2029)
-
1.4.3 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Glybera (2018-2029)
-
1.4.4 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Rexin-G (2018-2029)
-
1.4.5 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Neovasculgen (2018-2029)
-
1.4.6 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Eteplirsen (2018-2029)
-
1.4.7 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.8 China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Spinraza (2018-2029)
-
1.5 China Drugs Based on Gene Therapy Market Analysis by Application from Consumption End
-
1.5.1 China Drugs Based on Gene Therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
1.5.2 China Drugs Based on Gene Therapy Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
1.5.3 China Drugs Based on Gene Therapy Sales Volume, Sales Value and Growth Rate of Neurological Diseases (2018-2029)
-
1.6 China Drugs Based on Gene Therapy Market Analysis by Region
-
1.6.1 North China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
Chapter 2 China Drugs Based on Gene Therapy Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Drugs Based on Gene Therapy Market Status and Competition at home and abroad in 2023
-
2.2.2 China Drugs Based on Gene Therapy Market Status and Competition Analysis in 2023
-
2.2.3 China Drugs Based on Gene Therapy Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Drugs Based on Gene Therapy Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Drugs Based on Gene Therapy Industry Development
Chapter 3 Drugs Based on Gene TherapyIndustry Chain Analysis
-
3.1 Drugs Based on Gene Therapy Industry Chain
-
3.2 Drugs Based on Gene Therapy Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Drugs Based on Gene Therapy Market
-
3.3 Drugs Based on Gene Therapy Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Drugs Based on Gene Therapy Market
Chapter 4 China Drugs Based on Gene Therapy Market, by Type
-
4.1 China Drugs Based on Gene Therapy Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Drugs Based on Gene Therapy Total Production Volume and Growth Rate from Production Side
-
4.5 China Drugs Based on Gene Therapy Production Volume and Growth Rate, by Type
-
4.5.1 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Defitelio
-
4.5.2 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Onpattro
-
4.5.3 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Glybera
-
4.5.4 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Rexin-G
-
4.5.5 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Neovasculgen
-
4.5.6 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Eteplirsen
-
4.5.7 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Others
-
4.5.8 China Drugs Based on Gene Therapy Production Volume and Growth Rate of Spinraza
Chapter 5 China Drugs Based on Gene Therapy Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Drugs Based on Gene Therapy Total Market Size and Growth Rate from Consumption End
-
5.5 China Drugs Based on Gene Therapy Market Size and Growth Rate, by Application
-
5.5.1 China Drugs Based on Gene Therapy Market Size and Growth Rate of Other
-
5.5.2 China Drugs Based on Gene Therapy Market Size and Growth Rate of Cancer
-
5.5.3 China Drugs Based on Gene Therapy Market Size and Growth Rate of Neurological Diseases
Chapter 6 China Drugs Based on Gene Therapy Market, by Region
-
6.1 China Drugs Based on Gene Therapy Production Volume and Production Value, by Region
-
6.2 China Drugs Based on Gene Therapy Sales Volume and Sales Value, by Region
Chapter 7 North China Drugs Based on Gene Therapy Market Analysis
-
7.1 North China Drugs Based on Gene Therapy Market, by Type
-
7.2 North China Drugs Based on Gene Therapy Market, by Application
Chapter 8 Central China Drugs Based on Gene Therapy Market Analysis
-
8.1 Central China Drugs Based on Gene Therapy Market, by Type
-
8.2 Central China Drugs Based on Gene Therapy Market, by Application
Chapter 9 South China Drugs Based on Gene Therapy Market Analysis
-
9.1 South China Drugs Based on Gene Therapy Market, by Type
-
9.2 South China Drugs Based on Gene Therapy Market, by Application
Chapter 10 East China Drugs Based on Gene Therapy Market Analysis
-
10.1 East China Drugs Based on Gene Therapy Market, by Type
-
10.2 East China Drugs Based on Gene Therapy Market, by Application
Chapter 11 Northeast China Drugs Based on Gene Therapy Market Analysis
-
11.1 Northeast China Drugs Based on Gene Therapy Market, by Type
-
11.2 Northeast China Drugs Based on Gene Therapy Market, by Application
Chapter 12 Southwest China Drugs Based on Gene Therapy Market Analysis
-
12.1 Southwest China Drugs Based on Gene Therapy Market, by Type
-
12.2 Southwest China Drugs Based on Gene Therapy Market, by Application
Chapter 13 Northwest China Drugs Based on Gene Therapy Market Analysis
-
13.1 Northwest China Drugs Based on Gene Therapy Market, by Type
-
13.2 Northwest China Drugs Based on Gene Therapy Market, by Application
Chapter 14 Company Profiles
-
14.1 bluebird bio
-
14.1.1 bluebird bio Company Profile
-
14.1.2 bluebird bio Drugs Based on Gene Therapy Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Gilead Sciences
-
14.2.1 Gilead Sciences Company Profile
-
14.2.2 Gilead Sciences Drugs Based on Gene Therapy Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Alnylam Pharmaceuticals
-
14.3.1 Alnylam Pharmaceuticals Company Profile
-
14.3.2 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Orchard Therapeutics
-
14.4.1 Orchard Therapeutics Company Profile
-
14.4.2 Orchard Therapeutics Drugs Based on Gene Therapy Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Sunway Biotech
-
14.5.1 Sunway Biotech Company Profile
-
14.5.2 Sunway Biotech Drugs Based on Gene Therapy Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 AnGes
-
14.6.1 AnGes Company Profile
-
14.6.2 AnGes Drugs Based on Gene Therapy Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Biogen
-
14.7.1 Biogen Company Profile
-
14.7.2 Biogen Drugs Based on Gene Therapy Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Sarepta Therapeutics
-
14.8.1 Sarepta Therapeutics Company Profile
-
14.8.2 Sarepta Therapeutics Drugs Based on Gene Therapy Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Human Stem Cells Institute
-
14.9.1 Human Stem Cells Institute Company Profile
-
14.9.2 Human Stem Cells Institute Drugs Based on Gene Therapy Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Amgen
-
14.10.1 Amgen Company Profile
-
14.10.2 Amgen Drugs Based on Gene Therapy Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Spark Therapeutics
-
14.11.1 Spark Therapeutics Company Profile
-
14.11.2 Spark Therapeutics Drugs Based on Gene Therapy Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Novartis
-
14.12.1 Novartis Company Profile
-
14.12.2 Novartis Drugs Based on Gene Therapy Market Performance
-
14.12.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Drugs Based on Gene Therapy Industry Research Conclusions
-
15.2 Drugs Based on Gene Therapy Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Drugs Based on Gene Therapy Industry Market Size (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Defitelio (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Onpattro (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Glybera (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Rexin-G (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Neovasculgen (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Eteplirsen (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Drugs Based on Gene Therapy Production Volume, Production Value and Growth Rate of Spinraza (2018-2029)
-
Figure China Drugs Based on Gene Therapy Sales Volume, Sales Value and Growth Rate of Other (2018-2029)
-
Figure China Drugs Based on Gene Therapy Sales Volume, Sales Value and Growth Rate of Cancer (2018-2029)
-
Figure China Drugs Based on Gene Therapy Sales Volume, Sales Value and Growth Rate of Neurological Diseases (2018-2029)
-
Figure North China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Central China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure South China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure East China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Drugs Based on Gene Therapy Market Size and Growth Rate from 2018-2029
-
Figure Drugs Based on Gene Therapy Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Drugs Based on Gene Therapy Market Share by Type in 2018
-
Figure China Drugs Based on Gene Therapy Market Share by Type in 2023
-
Figure China Drugs Based on Gene Therapy Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Defitelio (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Onpattro (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Glybera (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Rexin-G (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Neovasculgen (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Eteplirsen (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume and Growth Rate of Spinraza (2018-2023)
-
Figure China Drugs Based on Gene Therapy Market Share by Application in 2018
-
Figure China Drugs Based on Gene Therapy Market Share by Application in 2023
-
Figure China Drugs Based on Gene Therapy Total Market Size and Growth Rate from Consumption End
-
Figure China Drugs Based on Gene Therapy Market Size and Growth Rate of Other (2018-2023)
-
Figure China Drugs Based on Gene Therapy Market Size and Growth Rate of Cancer (2018-2023)
-
Figure China Drugs Based on Gene Therapy Market Size and Growth Rate of Neurological Diseases (2018-2023)
-
Table China Drugs Based on Gene Therapy Production Volume by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Production Volume Share by Region (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Volume Share by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Production Value by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Production Value Share by Region (2018-2023)
-
Figure China Drugs Based on Gene Therapy Production Value Share by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Sales Volume by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Sales Volume Share by Region (2018-2023)
-
Figure China Drugs Based on Gene Therapy Sales Volume Share by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Sales Value by Region (2018-2023)
-
Table China Drugs Based on Gene Therapy Sales Value Share by Region (2018-2023)
-
Figure China Drugs Based on Gene Therapy Sales Value Share by Region (2018-2023)
-
Table North China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table North China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure North China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table North China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table North China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure North China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Central China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table Central China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Central China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Central China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table Central China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Central China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table South China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table South China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure South China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table South China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table South China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure South China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table East China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table East China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure East China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table East China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table East China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure East China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Northeast China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table Northeast China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Northeast China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Northeast China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table Northeast China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Southwest China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table Southwest China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Southwest China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Southwest China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table Southwest China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table Northwest China Drugs Based on Gene Therapy Production Volume by Type (2018-2023)
-
Table Northwest China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Figure Northwest China Drugs Based on Gene Therapy Production Volume Share by Type (2018-2023)
-
Table Northwest China Drugs Based on Gene Therapy Sales Volume by Application (2018-2023)
-
Table Northwest China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Drugs Based on Gene Therapy Sales Volume Share by Application (2018-2023)
-
Table bluebird bio Company Profile
-
Table bluebird bio Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Gilead Sciences Company Profile
-
Table Gilead Sciences Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Alnylam Pharmaceuticals Company Profile
-
Table Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Orchard Therapeutics Company Profile
-
Table Orchard Therapeutics Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Sunway Biotech Company Profile
-
Table Sunway Biotech Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table AnGes Company Profile
-
Table AnGes Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Biogen Company Profile
-
Table Biogen Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Sarepta Therapeutics Company Profile
-
Table Sarepta Therapeutics Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Human Stem Cells Institute Company Profile
-
Table Human Stem Cells Institute Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Amgen Company Profile
-
Table Amgen Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Spark Therapeutics Company Profile
-
Table Spark Therapeutics Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Drugs Based on Gene Therapy Revenue, Price and Gross (2018-2023)
-
